Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
06/2014
06/24/2014US8759499 Lipids for transfection of Eukaryotic cells
06/24/2014US8759314 Methods for treating multiple sclerosis using antisense oligonucleotides
06/24/2014US8759312 Methods and compositions for reducing viral genome amounts in a target cell
06/24/2014US8759310 Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
06/24/2014US8759308 RNAi probes targeting cancer-related proteins
06/24/2014US8759307 Oligonucleotide compound and method for treating nidovirus infections
06/24/2014US8759305 Methods and compositions for inhibition of innate immune responses and autoimmunity
06/24/2014US8759286 Pharmaceutical compositions comprising a VEGF-D polypeptide
06/24/2014US8758998 Construction of bifunctional short hairpin RNA
06/19/2014WO2014093950A1 Immune modulator for immunotherapy and vaccine formulation
06/19/2014WO2014093924A1 Modified nucleic acid molecules and uses thereof
06/19/2014WO2014093836A1 Ossification-inducing composition and methods of use thereof
06/19/2014WO2014093531A1 Modulation of myofiber repair by anti-myostatin in strategies with stem cells
06/19/2014WO2014093479A1 Crispr (clustered regularly interspaced short palindromic repeats) rna-guided control of gene regulation
06/19/2014WO2014093270A1 Tropism modified cancer terminator virus (ad.5/3 ctv;ad.5/3-ctv-m7)
06/19/2014WO2014055413A3 A method of providing cellular therapy using modified natural killer cells or t lymphocytes
06/19/2014WO2014018423A8 Inducible dna binding proteins and genome perturbation tools and applications thereof
06/19/2014US20140170710 Methods and compositions for seamless cloning of nucleic acid molecules
06/19/2014US20140170063 Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
06/18/2014EP2742944A1 Immune tolerance inducer
06/18/2014EP2742128A1 Compositions and methods for inducing apoptosis
06/18/2014EP2741821A1 Methods of treating dna damage
06/18/2014EP2741785A2 Novel clostridium difficile dna vaccine
06/18/2014EP2741784A1 Fus1/tusc2 therapies
06/18/2014EP2741783A1 Polyanion nanocomplexes for therapeutic applications
06/18/2014EP2741764A2 Compositions and methods for regulating neutrophil movement and neutrophil numbers in a body region
06/18/2014EP2741757A1 Compositions of functional mitochondria and uses thereof
06/18/2014CN103866018A MicroRNA-Based Methods and Compositions For the Diagnosis, Prognosis and Treatment of Breast Cancer
06/18/2014CN103866017A MicroRNA-Based Methods and Compositions For the Diagnosis, Prognosis and Treatment of Breast Cancer
06/18/2014CN103866008A Ultraconserved regions encoding ncrnas
06/18/2014CN103865934A Bungatotoxin antigen epitope gene and application of bungatotoxin antigen epitope gene to preparation of gene vaccine and antigen
06/18/2014CN103865890A Recombinant virus for preventing viral myocarditis as well as vaccine and applications tof recombinant virus
06/18/2014CN103864936A HPV18 type L2NE7E6 fusion protein gene, and expression vector, preparation method, strain and use thereof
06/18/2014CN103864907A Protein and kit for tuberculosis diagnosis
06/18/2014CN103864902A Bivalent DNA vaccine connecting peptide and applications thereof
06/18/2014CN103864893A Novel immunogenic epitopes for immunotherapy
06/18/2014CN103861127A SPIO-shRNA (superparamagnetic iron oxide-short hair ribonucleic acid) molecular probe with dual actions of MR (magnetic resonance) gene imaging and targeting therapy
06/18/2014CN103861122A miRNA of negatively regulating I type interferon pathway and application of miRNA
06/18/2014CN103861121A Use of micro-RNA molecule miR491-5p in treatment and/or diagnosis and/or prognosis of pancreatic cancer
06/18/2014CN103861112A Pharmaceutical composition based on polymer nanoparticle carrier and preparation method thereof
06/18/2014CN103861099A VACCINE ADJUVANT, VACCINE COMPOSITION AND usage of Antrodia camphorate sporocarp
06/18/2014CN103861093A Sheep hydatid cyst subunit vaccine, and preparation method and application thereof
06/18/2014CN103272233B Application of MLL (mixed lineage leukemia) 1 antibody and expression inhibiter in preparing medicine for treating AML (acute myeloid leukemia)
06/18/2014CN102988976B Hepatitis B virus core antigen-DNA (deoxyribonucleic acid) compound vaccine and preparation method thereof
06/18/2014CN102949729B Active targeting type small interfering ribonucleic acid (siRNA) delivery carrier and preparation method thereof
06/18/2014CN102911261B Agrocybe aegerita lectin AAL-2 and coding gene thereof, preparation method and application thereof
06/18/2014CN102827251B Transmembrane peptide-mediated antisense antibacterial agent and preparation method and application thereof
06/18/2014CN102784398B Composition comprising endostatin adopted as delivery system and chemically-synthesized RNA interference molecule, and application thereof
06/18/2014CN102732533B Vaccine produced by using Cryptocaryon irritans immbolization antigen to complement deoxyribonucleic acid, and production method and application thereof
06/18/2014CN102603885B Alexin and application thereof to preparation of antibacterial medicament
06/18/2014CN102558569B Lipopolysaccharide amine cationic polymer and preparation method and application thereof
06/18/2014CN102392049B Preparation method for hepatitis E virus antigen and product thereof
06/17/2014US8754201 Therapeutic compositions
06/17/2014US8754062 DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotides
06/17/2014US8754061 Nucleic acid construct containing a nucleic acid derived from the genome of hepatitis C virus (HCV) of genotype 2a, and a cell having such nucleic acid construct introduced therein
06/17/2014US8754059 Use of miR-30e to treat vascular lesions
06/17/2014US8754057 Inhibition of apoptosis-specific eIF-5A(eIF-5A1″) with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics
06/17/2014US8754055 Methods, compositions, and kits for collecting and detecting oligonucleotides
06/17/2014US8754046 MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1
06/17/2014US8754031 Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathway
06/17/2014US8754030 Defensin-antigen fusion proteins
06/17/2014US8753650 Staphylococcus aureus proteins and nucleic acids
06/17/2014US8753648 Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods
06/17/2014CA2690828C Composition containing microrna-21 inhibitor for enhancing radiation sensitivity
06/17/2014CA2628306C Immunostimulatory oligonucleotide-based compounds with glycerol-linked dinucleotides and modified guanosines at cpg and uses thereof
06/17/2014CA2613310C Use of mutant herpes simplex virus-2 for cancer therapy
06/12/2014WO2014089544A2 High power lasers, wavelength conversions, and matching wavelengths use environments
06/12/2014WO2014089239A1 Improved nucleic acid lipid particle formulations
06/12/2014WO2014089124A1 Immunogenic compositions for inducing an immune response for elimination of senescent cells
06/12/2014WO2014088292A1 Pharmaceutical composition comprising inhibitor of expression or activation of carbonyl reductase 1 protein for preventing or treating colorectal cancer or inhibiting metastasis of same
06/12/2014WO2014087023A1 An amphipathic peptide
06/12/2014WO2014086243A1 Mirna molecule for negatively regulating type i interferon pathway and use thereof
06/12/2014WO2014036524A4 Genetically modified msc and therapeutic methods
06/12/2014US20140163084 Methods and compositions for controlling efficacy of rna silencing
06/12/2014US20140161887 Adjuvant compositions
06/12/2014US20140161859 Dermal micro-organs, methods and apparatuses for producing and using the same
06/12/2014US20140161816 Anti- tnf antibodies, compositions, methods and uses
06/11/2014EP2740793A1 Drug composition for cancer treatment and/or prevention
06/11/2014EP2739300A2 N-terminal deleted gp120 immunogens
06/11/2014CN103857406A Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
06/11/2014CN103849652A Nano carrier compound for microRNA (Ribonucleic Acid) targeting delivery and preparation method and application thereof
06/11/2014CN103849637A O-type foot and mouth disease virus acid-resistant mutant strain, capsid protein carried by O-type foot and mouth disease virus acid-resistant mutant strain, coding gene of capsid protein and use of O-type foot and mouth disease virus acid-resistant mutant strain and capsid protein
06/11/2014CN103848751A Ionizable cation lipid compound and application thereof
06/11/2014CN103145849B Chimeric antigen receptor and use thereof
06/11/2014CN103045597B Small nucleotide hsa-miR-1909 and application thereof
06/11/2014CN103028121B miR-21 compound of target microglial cell and preparation method and application of miR-21 compound
06/11/2014CN102899327B Antiviral small nucleic acid and temperature-sensitive type gel preparation and application thereof
06/11/2014CN102786582B Tem8 peptides and vaccines comprising the same
06/11/2014CN102183655B New molecular marker CUEDC2 (CUE Domain Containing 2) protein for prognosis judgement in endocrine therapy of breast cancer
06/11/2014CN101899471B Recombinant retrovirus vector for simultaneously expressing antigen-specific receptor and exogenous gene, B-lymphocyte modified by using same and application thereof
06/11/2014CN101897981B Method for inhibiting proliferation and inducing apoptosis of cancer cells and use thereof
06/10/2014US8748592 siRNA for inhibition of OTUB1 expression and pharmaceutical composition containing the same
06/10/2014US8748405 Methods and compositions for the treatment of cancer or other diseases
06/10/2014US8748404 DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus
06/10/2014US8748403 Modulation of HSV infection
06/10/2014US8748179 Method for efficient production of induced pluripotent stem cells utilizing cells derived from oral mucosa
06/10/2014US8748171 Cell population enriched for endoderm cells
06/10/2014US8748169 Methods and compositions relating to restricted expression lentiviral vectors and their applications
06/10/2014US8747904 Polymeric micelles for polynucleotide encapsulation
06/10/2014US8747864 Staphylococcus aureus proteins and nucleic acids
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 870